Por: Associated Press Politics December 18, 2022
WASHINGTON (AP) — For two years, Becky Mourey pushed the Food and Drug Administration to approve an experimental drug for her Lou Gehrig’s disease.She went to and health regulators to make the case for Relyvrio, until patient-advocates finally prevailed. In September, Relyvrio became only the third drug approved in the U.S. for ALS, or amyotrophic lateral sclerosis, an incurable neurodegenerative disease that is usually fatal within five... + full article
10 WBNS USA Nation December 19, 2022
WASHINGTON — For two years, Becky Mourey pushed the Food and Drug Administration to approve an experimental drug for her Lou Gehrig’s disease. She went to and health regulators to make the case for Relyvrio, until patient-advocates finally prevailed. In September, Relyvrio... + más
ALS patients contend with $158K price tag on new drug | ABC News
ALS patients contend with $158K price tag on new drug | Associated Press
Los Angeles Times USA World December 19, 2022
For two years, Becky Mourey pushed the Food and Drug Administration to approve an experimental drug for her Lou Gehrig’s disease. She went to members of Congress and health regulators to make the case for Relyvrio, until patient-advocates finally prevailed. In September,... + más
ABC News USA Health December 18, 2022
WASHINGTON -- For two years, Becky Mourey pushed the Food and Drug Administration to approve an experimental drug for her Lou Gehrig’s disease.She went to members of Congress and regulators to make the case for Relyvrio, until patient-advocates finally prevailed. In September,... + más
ALS patients contend with $158K price tag on new drug | 10 WBNS
WPTV USA Nation October 04, 2022
Imagine being trapped in a paralyzed body. That's how the describes the progression of a neurological disease called ALS, which 31,000 people in the United States are living with.Thankfully, there is hope for a better quality of life thanks to a drug that the Food and Drug... + más
FDA approves ALS drug partly funded by Ice Bucket Challenge | 10 WBNS
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
ABC News USA Health September 30, 2022
WASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más
ALS drug wins FDA approval despite questionable data | ABC News
New York Post USA Life September 30, 2022
A much-debated drug for Lou Gehrig’s disease won US approval on Thursday from the Food and Drug Administration. The nod represents a long-desired victory for patients, though it is likely to renew questions about the scientific rigor behind government reviews of... + más
ALS drug gets FDA approval despite uncertainty about effectiveness | ABC7
PennLive USA Nation September 30, 2022
WASHINGTON — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más
About iurex | Privacy Policy | Disclaimer |